Styrenyl derivative compounds for treating ophthalmic...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 211/26 (2006.01) A61K 31/137 (2006.01) A61P 27/02 (2006.01) C07C 215/00 (2006.01) C07D 295/03 (2006.01)

Patent

CA 2681850

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

L'invention concerne des compositions et des procédés pour traiter des maladies et des troubles neurodégénératifs, en particulier des maladies et des troubles ophtalmiques. Des composés dérivés de styrényle sont fournis, incluant mais n'étant pas limités à ceux-ci des composés dérivés de stilbène, et aux compositions comprenant ces composés, qui sont utiles pour traiter et empêcher des maladies et des troubles ophtalmiques, y compris la dégénération maculaire relative à l'âge (AMD) et la maladie de Stargardt.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Styrenyl derivative compounds for treating ophthalmic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Styrenyl derivative compounds for treating ophthalmic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Styrenyl derivative compounds for treating ophthalmic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1459927

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.